Searched for
NEULAND PHARMA RESEARCH
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 26%On Thursday evening, US President Trump said he would “hit Iran hard tonight”. Then, as the world waited with bated breath, came the announ...- Stock picks of the week; 5 stocks with consistent score improvement and upside potential of up to 25%Even in normal times it is futile to try and guess the outcome of most global events. But in the New World Order, it makes no sense at all ...
- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Looking at mid-caps? Keep your portfolio healthy: 5 mid-cap pharma stocks with an upside potential of up to 38%Even as the bears are running wild on the street causing across-the-board damage, there are sectors that have kept them at bay. And that’s ...
- Pharma stocks catch a cold as US softens stance on Biosecure ActShares of Syngene International dropped 5.7%, Piramal Pharma fell 4.2%, Lauras Labs and Neuland Laboratories declined 3% and Divi's Laborat...
- Buy RIL, sell Jio Financial: How mutual funds tweaked stock portfolios in AprilFor three consecutive months, MFs bought shares of Reliance Industries, HDFC Bank, Hindustan Unilever, Axis Bank and ONGC. During the same ...
- MSCI index rejig may result in $1.4b inflows into stocksMSCI added 40 stocks to its Global Smallcap Index and removed 11. India has seen the maximum addition of stocks in the Global Smallcap Inde...
- HDFC AMC, IDFC First Bank & 6 other stocks enter MSCI Global index; ACC exitsACC, Anand Rathi Wealth, Dreamfolks Services, Five Star Business Finance, Glenmark Lifesciences, ICRA, Kalyan Jewellers, Marksans Pharma, M...
- Nifty Pharma index hits a new high as investors lap up defensivesThe Nifty Pharma Index jumped 1.56% on Monday to close at 15,479.25 as against the 0.4% advance in the benchmark Nifty. While the pharma in...
- Wealth destroyer alert! 280 stocks tank up to 70% in FY22Majority of the laggards have been hit by rich valuations, muted earnings, abysmal corporate governance and destitute fundamentals, whereas...
- Should you be positive on ITC? Siddhartha Khemka answersEven if the numbers for the other segments improve, the numbers from ITC’s core segment will continue to be suppressed, says the MOFSL’s re...
- 80% return in 95 sessions! Analysts say this Dark Horse has miles to runAnalysts are largely retaining their bullish view on the sector, but some have advised investors to stay stock-specific after the huge rall...
- These 15 smallcaps swung to profit after 5 quarters; worth a look?As a whole, India Inc saw sales growth of more than 10 per cent YoY for Q4 of FY18.
- Market Now: Pharma stocks mixed; Cipla cracks 5%The BSE Healthcare index was trading 0.45 per cent down at 13,324 around 10:10 am (IST).
- Evolvence India Fund to exit Neuland Labs; puts entire stake of 33 per cent on saleVishy Chebrol, one of the founders and managing directors of InvAscent, confirmed the fund is looking at exiting its investment in the comp...
- Bullish on Camson Bio Tech, Astra Micro and Neuland Laboratories: Jagannadham Thunuguntla, Karvy Stock BrokingWe are bullish on Camson and whoever is having a 12 to 18-month perspective, I feel the stock can be at much higher levels, may be towards ...
- Neuland Labs to focus on contract researchHyderabad-based mid-sized pharma player Neuland Labs has raised $30 million for capital expenditure on contract research facilities and its...
- Dishman Pharma acquires Swiss Co for $75 mnDishman Pharmaceuticals and Chemicals Ltd on Wednesday said it has acquired Swiss Research based company Cabbogen Amcis AG from Solutia Eur...
Load More
